Beiersdorf has entered the digital dermatology space. The company purchased a stake in the startup Dermanostic through its Oscar & Paul venture capital unit. Dermanostic offers app-based dermatological diagnosis. The service can be booked around the clock for 25 euros irrespective of location, with the diagnoses then performed by experienced dermatologists within 24 hours once the patients have uploaded three photos and filled out a medical history questionnaire. In less serious cases in particular, Dermanostic can eliminate the need for a patient to visit a dermatological practice and can provide fast solutions for an individual skin problem, for example by sending the prescription by mail or digitally via online pharmacies.
“Digital dermatologist appointments offer our consumers significant added value as they allow for swift, straightforward, inexpensive, and professional advice regarding their skin indication,” said Ascan Voswinckel, head of Oscar & Paul Beiersdorf Venture Capital. “As such, Dermanostic’s new digital service is the perfect fit for our Eucerin brand and innovatively complements our dermocosmetic brand’s digital consumer journey.”
A purchase price was not disclosed. The companies agreed that they share the same goal—offering solutions to individual skin problems.
“We are delighted to have Beiersdorf at our side as a strong and experienced partner,” says Dr. Ole Martin, managing director and cofounder, Dermanostic. “In the past few months alone, we have seen what a good match Dermanostic and Eucerin are.”
As part of the cooperation, interested users can find information about Dermanostic’s services on a dedicated landing page.